Background Second generation drug-eluting stents were developed to improve the safety and efficacy of first generation stents. So far, limited long term randomized data exist comparing the second gene
Report of Rapamycin Target Eluting Stent System Market is currently supplying a comprehensive analysis of many things which are liable for economy growth and factors which could play an important part
Drug Eluting Stents comes with extensive industry analysis of development components, patterns, flows, and sizes. The report calculates present and past market values to forecast potential market mana
Introduction : Despite advances in drug-eluting stent (DES) technology, stent thrombosis (ST) remains the most feared complication with high morbidity and mortality. Areas covered : Stent
